Annual D&A
$2.06 M
+$105.00 K+5.37%
December 1, 2024
Summary
- As of March 10, 2025, JANX annual depreciation & amortization is $2.06 million, with the most recent change of +$105.00 thousand (+5.37%) on December 1, 2024.
- During the last 3 years, JANX annual D&A has risen by +$1.95 million (+1723.01%).
- JANX annual D&A is now at all-time high.
Performance
JANX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$512.00 K
+$2000.00+0.39%
December 1, 2024
Summary
- As of March 10, 2025, JANX quarterly depreciation & amortization is $512.00 thousand, with the most recent change of +$2000.00 (+0.39%) on December 1, 2024.
- Over the past year, JANX quarterly D&A has stayed the same.
- JANX quarterly D&A is now -3.76% below its all-time high of $532.00 thousand, reached on March 31, 2024.
Performance
JANX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.06 M
-$19.00 K-0.91%
December 1, 2024
Summary
- As of March 10, 2025, JANX TTM depreciation & amortization is $2.06 million, with the most recent change of -$19.00 thousand (-0.91%) on December 1, 2024.
- Over the past year, JANX TTM D&A has stayed the same.
- JANX TTM D&A is now -0.91% below its all-time high of $2.08 million, reached on September 30, 2024.
Performance
JANX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
JANX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | 0.0% | 0.0% |
| 3 y3 years | +1723.0% | 0.0% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% | 0.0% |
JANX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1723.0% | -3.8% | +700.0% | -0.9% | +1723.0% |
| 5 y | 5-year | at high | >+9999.0% | -3.8% | >+9999.0% | -0.9% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -3.8% | >+9999.0% | -0.9% | >+9999.0% |
Janux Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.06 M(+5.4%) | $512.00 K(+0.4%) | $2.06 M(-0.9%) |
| Sep 2024 | - | $510.00 K(+0.8%) | $2.08 M(+0.5%) |
| Jun 2024 | - | $506.00 K(-4.9%) | $2.07 M(+1.7%) |
| Mar 2024 | - | $532.00 K(+0.2%) | $2.03 M(+4.0%) |
| Dec 2023 | $1.96 M(+132.5%) | $531.00 K(+6.2%) | $1.96 M(+7.0%) |
| Sep 2023 | - | $500.00 K(+6.2%) | $1.83 M(+15.9%) |
| Jun 2023 | - | $471.00 K(+4.0%) | $1.58 M(+29.9%) |
| Mar 2023 | - | $453.00 K(+12.4%) | $1.21 M(+44.2%) |
| Dec 2022 | $841.00 K | $403.00 K(+61.8%) | $841.00 K(+67.5%) |
| Sep 2022 | - | $249.00 K(+130.6%) | $502.00 K(+79.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $108.00 K(+33.3%) | $280.00 K(+51.4%) |
| Mar 2022 | - | $81.00 K(+26.6%) | $185.00 K(+63.7%) |
| Dec 2021 | $113.00 K(+769.2%) | $64.00 K(+137.0%) | $113.00 K(+94.8%) |
| Sep 2021 | - | $27.00 K(+107.7%) | $58.00 K(+81.3%) |
| Jun 2021 | - | $13.00 K(+44.4%) | $32.00 K(+60.0%) |
| Mar 2021 | - | $9000.00(0.0%) | $20.00 K(+53.8%) |
| Dec 2020 | $13.00 K(+116.7%) | $9000.00(+800.0%) | $13.00 K(+225.0%) |
| Sep 2020 | - | $1000.00(0.0%) | $4000.00(+33.3%) |
| Jun 2020 | - | $1000.00(-50.0%) | $3000.00(+50.0%) |
| Mar 2020 | - | $2000.00 | $2000.00 |
| Dec 2019 | $6000.00 | - | - |
FAQ
- What is Janux Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Janux Therapeutics?
- What is Janux Therapeutics annual D&A year-on-year change?
- What is Janux Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Janux Therapeutics?
- What is Janux Therapeutics quarterly D&A year-on-year change?
- What is Janux Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Janux Therapeutics?
- What is Janux Therapeutics TTM D&A year-on-year change?
What is Janux Therapeutics annual depreciation & amortization?
The current annual D&A of JANX is $2.06 M
What is the all time high annual D&A for Janux Therapeutics?
Janux Therapeutics all-time high annual depreciation & amortization is $2.06 M
What is Janux Therapeutics annual D&A year-on-year change?
Over the past year, JANX annual depreciation & amortization has changed by +$105.00 K (+5.37%)
What is Janux Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of JANX is $512.00 K
What is the all time high quarterly D&A for Janux Therapeutics?
Janux Therapeutics all-time high quarterly depreciation & amortization is $532.00 K
What is Janux Therapeutics quarterly D&A year-on-year change?
Over the past year, JANX quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Janux Therapeutics TTM depreciation & amortization?
The current TTM D&A of JANX is $2.06 M
What is the all time high TTM D&A for Janux Therapeutics?
Janux Therapeutics all-time high TTM depreciation & amortization is $2.08 M
What is Janux Therapeutics TTM D&A year-on-year change?
Over the past year, JANX TTM depreciation & amortization has changed by $0.00 (0.00%)